Клинические исследования


The aims of the Clinical Trials Standing Committee are to:

  • provide investigators with authoritative guidelines for randomised controlled trials (RCTs) in the major headache disorders, especially migraine, tension-type headache and cluster headache
  • draw on the experience of senior clinical investigators and those working in the field in the pharmaceutical industry to develop, elaborate, and from time to time update these guidelines
  • advise medicines regulatory agencies who may be producing notes for guidance in the clinical development of drugs, devices or other treatments for use against headache disorders
  • otherwise support and promote evidence-based headache medicine.

To access all published Clinical Trial guidelines please visit the Guidelines page.

Наши члены


Gisela M Terwindt

Gisela M Terwindt


Read Profile

Vice Chairs

  • Hans-Christoph Diener
  • Cristina Tassorelli

Наши члены

  • Messoud Ashina
  • Peter Goadsby
  • Elizabeth Leroux
  • Richard Lipton
  • Patricia Pozo Rosich
  • Shuu-Jiun Wang

Junior members

  • Marie Deen Christensen
  • Daniele Martini
  • Thomas van den Hoek

Мероприятия и новости

The Clinical Trials Standing Committee has produced methodological guidelines on the design, conduct and analysis of controlled trials of drugs for treatment or prevention of migraine, tension-type headache, cluster headache, chronic migraine and adverse events.

The Committee is also currently involved in the development of other IHS Guidelines, such as Health Technology Assessment and evidence-based grade tables.

Ежегодные отчеты